DIA
Drug Information Association Logo

Advanced Search

Student & Professional Posters

Search Poster Presentation 

Poster Number Poster Title Poster Type Date/Time Poster Presenter
M 01 Effect Of Formulation pH On Micropore Closure In Microneedle Enhanced Transdermal Drug Delivery Student Mon, Jun 25 11:00AM Priyanka Ghosh
M 02 Improvement of Obstetrics and Gynecology Patient Health by Using Patient Safety Reporting System Student Mon, Jun 25 11:00AM Neha Dhananjay Nandedkar
M 03 An Evaluation of the Gulf Cooperation Council (GCC) Centralized Regulatory Review Process for Pharmaceutical Products Student Mon, Jun 25 11:00AM Ph. Mohammed Hamdan Al Rubaie
M 04 Psychotropic Drug Use Among Autistic Individuals Enrolled In A State Medicaid Fee-for-service Program Student Mon, Jun 25 11:00AM Krutika Jariwala
M 05 Using Stochastic Control Methods and Pharmacokinetics to Individualize Drug Therapy Student Mon, Jun 25 11:00AM Ben Francis
M 06 Seeking Predictable Subject Characteristics That Influence Clinical Trial Discontinuation. Student Mon, Jun 25 11:00AM Jai Shankar Kishore Babu Yadlapalli
M 07 Evaluating Consumer Understanding of Prescription Label Information: An Assessment of USP 2011 Recommendations Student Mon, Jun 25 11:00AM Megan Elizabeth Bensi
M 08 Development and Application of a Universal Benefit-risk Assessment Framework for Medicines Student Mon, Jun 25 11:00AM James Leong
M 09 Examination of the Adoption of FDA's Bio-pharmaceutics Classification System (BCS): A Qualitative Study Student Mon, Jun 25 11:00AM Namita Joshi
M 10 Influence of Patient and Hospital Level Characteristics on Emergency Department (ED) Wait Time in US Student Mon, Jun 25 11:00AM Hemalkumar B Mehta
M 11 Bias Assessment in Progression-Free Survival Analysis Using Interval-Censored Methods Student Mon, Jun 25 11:00AM Chen Hu
M 12 Contract Research Organizations in China: Current and Future Student Mon, Jun 25 11:00AM Yunzhen Shi
M 13 The Death of New Racemic Drugs Was an Exaggeration Student Mon, Jun 25 11:00AM Enav Zipora Zusman
M 14 Drug Adverse Events Surveillance with CDISC Standards for Multiple Trials Student Mon, Jun 25 11:00AM Boram Wang
M 15 Unmet Drug Information Needs and Clinical Adherence to Immunosuppressant Drugs of Kidney Transplant Recipients Student Mon, Jun 25 11:00AM Minghui Li
M 16 Pharmacovigilance and Drug Repurposing Model and Application: A Case Study Using Electronic Health Record Data Student Mon, Jun 25 11:00AM Krystl Haerian
M 17 Pursuing Orphan Designation in Japan: Benefits and Process Student Mon, Jun 25 11:00AM Monique Meigio
M 18 Influence of Clinical Research Investigator Fraud on Clinical Trial Participation Student Mon, Jun 25 11:00AM Purnachandra Garimella
M 19 Recommendations for Improving e-Prescribing Technology Design and Use in Pharmacies Student Mon, Jun 25 11:00AM Olufunmilola Odukoya
M 20 A Probabilistic Sensitivity Analysis to Estimate the Impact of Data Errors in a Randomized Trial to Eradicate H. pylori Student Mon, Jun 25 11:00AM Elisa L. Priest
T 01 Risk Evaluation and Mitigation Strategy (REMS): 18-Month Assessment Report of Dalfampridine Extended Release 10 mg Tablets Professional Tue, Jun 26 11:00AM Calvin B Mai
T 02 Which ePRO Modality is Appropriate for your Study? Professional Tue, Jun 26 11:00AM Jennifer Ross
T 03 Situational Analysis of the Pharmacovigilance Activities in Brazilian Public Industries: Collaborate to Innovate is Essential Professional Tue, Jun 26 11:00AM Paulo Roberto Gomes dos Santos
T 04 The “Storyline Document”, A New Document Format for the Use in Pre-submission Meetings Professional Tue, Jun 26 11:00AM Sybille M Eibert
T 05 VVSymQ™: A Simple, Validated Measure of Varicose Vein (VV) Symptoms That Can Be Administered Daily Using a Personal Digital Assistant (PDA) Professional Tue, Jun 26 11:00AM Ellen Evans
T 06 Modeling and Simulation in Early Drug Development Professional Tue, Jun 26 11:00AM Nancy Wang
T 07 Clinical Research and Development on Western Drug and Traditional Chinese Medicine Interaction in Taiwan Professional Tue, Jun 26 11:00AM Huang Yuan-Chao
T 08 CDISC ODM End-to-End: One Sponsor’s Approach Professional Tue, Jun 26 11:00AM Stephane Auger
T 09 Safety Database Migration: Use of Standard E2B Files with Automated Loading as an Alternative to Traditional Migration Professional Tue, Jun 26 11:00AM Arvind Nagaraj
T 10 Survey of Pharmaceutical Industry Outcomes Liaison Practices Professional Tue, Jun 26 11:00AM Christopher M. Marrone
T 11 Making the Point: Emphasis of Claims in Prescription and Nonprescription Television Advertising Professional Tue, Jun 26 11:00AM Adrienne Faerber
T 12 The Effect of A-Bromo-4-Chlorocinnamaldehyde on Coxsackie Virus B3-induced Myocarditis and the Mechanisms Professional Tue, Jun 26 11:00AM Siwang Wang
T 13 Novel Approach to Literature Surveillance for Adverse Events using OvidSP and EndNote Auto-import Function and Customization Professional Tue, Jun 26 11:00AM Neal J. Grabowski
T 14 Capitalizing On U.S. Public Use Files To Answer Pharmacoeconomic Questions Professional Tue, Jun 26 11:00AM Alex Exuzides
T 15 Ustekinumab Risk Evaluation and Mitigation Strategy: Embarking and Executing on the New Era in Drug Safety Professional Tue, Jun 26 11:00AM Jack McGowen
T 16 Infliximab Risk Evaluation and Mitigation Strategy: Embarking and Executing on the New Era in Drug Safety Professional Tue, Jun 26 11:00AM Brenda Sarokhan
T 17 Golimumab Risk Evaluation and Mitigation Strategy: Embarking and Executing on the New Era in Drug Safety Professional Tue, Jun 26 11:00AM Ralph J. Dehoratius
T 18 Systematic MedDRA Upgrade in Clinical and Post-marketing Safety Databases Professional Tue, Jun 26 11:00AM Susan Li
T 19 Automated Semantic Web-mining for Analyzing Changes in Trial Records Over Time and Identifying Rescue Countries Professional Tue, Jun 26 11:00AM David J. Cocker
T 20 Managing Standards with Governance and a Data Warehouse Professional Tue, Jun 26 11:00AM John G. Garrity
T 21 Corporate Integrity Agreements: Comparison of Technology and Procedures and How They Have Changed Since Onset to Most Recent Professional Tue, Jun 26 11:00AM Tracy A. England
T 22 Efficiency and Cost Benefit Analysis of Narrative Automation Using Six Sigma as Compared to Industry-wide Benchmarking of Narrative Writing Using Traditional Methods and Resources Professional Tue, Jun 26 11:00AM Grace Lee
T 23 Clinical and Regulatory Considerations for the Development of Therapeutic HIV Vaccines Professional Tue, Jun 26 11:00AM Kelly Denice Whitley De Padilla
T 24 Building an Analytical Roadmap to Support the New Risk-Based Site and Data Monitoring Strategy Professional Tue, Jun 26 11:00AM DeAnn S. Hyder
T 25 R&D Knowledge Management starts with Higher Quality Data Professional Tue, Jun 26 11:00AM Bob O'Hara
T 26 Social Media and Pharmacovigilance: New Space for Signal Detection & Socialvigilance Professional Tue, Jun 26 11:00AM Maria Vazquez-Gragg
T 27 Regulatory Labeling Experiences with the PSUR Worksharing Process Professional Tue, Jun 26 11:00AM Eileen S. Kahn
T 28 Implementation Status of CTD, eCTD and Paper-free Applications: A Global Overview Professional Tue, Jun 26 11:00AM Rosanna Melchior
T 29 Autovaccine B7-H1IgV induced Antitumor Immunity and Enhanced HER2 DNA Vaccine-derived Immune Responses Professional Tue, Jun 26 11:00AM Yingqi Zhang
TBD Post-Doctoral Pharmaceutical Industry Fellowships: Perceptions of required core skills by trainees and preceptors/managers Professional Wed, Jun 27 11:00AM Lindsay Bohlander
W 01 A Comparison of Adverse Event Coding of Ophthalmic Medical Device Reports: MedDRA® and FDA Patient Problem Codes Professional Wed, Jun 27 11:00AM Osas Ayela-Uwangue
W 02 Patient Preferences for Reminders in Clinical Trials: Improving Both Compliance and Patient Experience Professional Wed, Jun 27 11:00AM Graham J. Nicholls
W 03 Feasibility of Remote Medical Monitoring in Clinical Research Utilizing Web-based Electronic Medical Record System Professional Wed, Jun 27 11:00AM Joshua Zhang
W 04 Virtual Technology Solutions: Gain Efficiencies and Increase Control Over Global Sample Inventories During Clinical Research Professional Wed, Jun 27 11:00AM Lori Ball
W 05 Application of Control Charting for Pharmacovigilance Signal Detection Professional Wed, Jun 27 11:00AM Neal J. Grabowski
W 06 Preparation of Compassionate Use Data for Quality Regulatory Submissions: Experience with Glucarpidase Development for Methotrexate Toxicity Professional Wed, Jun 27 11:00AM Claire Daugherty
W 07 The Impact of Patient Recruitment Methods on Data Quality Professional Wed, Jun 27 11:00AM Patricia Brown
W 08 The Gap Between Clinical Trials and Comparative Effectiveness: A Case Study Professional Wed, Jun 27 11:00AM Rachel Jao
W 09 The MURDOCK Community Registry and Biorepository: Collaboration as the Driving Core of a Translational Research Engine Professional Wed, Jun 27 11:00AM Douglas Wixted
W 10 Identification of Biomarkers in Gastric Cancer of Chinese Based on SNPs Screening and its Evaluation in Clinical Application Professional Wed, Jun 27 11:00AM Zhen Yan
W 11 Study of Unique Feature of Regulatory Framework Under Japanese Pharmaceutical Affairs Law in Japan Professional Wed, Jun 27 11:00AM Michel Mikhail
W 12 Validation of New Patient/Clinician Reported Outcome Tool- Capturing the Visual Impact of Varicose Veins Professional Wed, Jun 27 11:00AM Elizabeth P. Orfe
W 13 Innovative Strategies to Enhance Minority Recruitment for Clinical Trials Professional Wed, Jun 27 11:00AM Lenore T. Coleman
W 14 Regulatory CMC BLA and NDA Submissions: Differences and Correlations from Regulatory and Scientific Perspectives Professional Wed, Jun 27 11:00AM David Donne
W 15 Medical Device Development Project Management: Is a Paradigm Shift Needed? Professional Wed, Jun 27 11:00AM Bernard Robert Tyrrell
W 16 Results of Patient and Physician Survey regarding Mobile Social Media Adoption and Preferences Professional Wed, Jun 27 11:00AM Jim Zuffoletti
W 17 Implementation of a Pharma Company’s Publication Policy that Ensures Compliance in an Increasingly Scrutinized Environment Professional Wed, Jun 27 11:00AM Michelle Kissner
W 18 Pharma Quality Agreements Professional Wed, Jun 27 11:00AM Gloria Miller
W 19 Creating a Data-Driven and Quantitative Site Index Score for Optimal Site Selection Professional Wed, Jun 27 11:00AM Elizabeth Nielsen
W 20 Informatics - Linchpin or Afterthought of a Business Externalization Strategy Professional Wed, Jun 27 11:00AM Susan Butler
W 22 Statistical Evaluation of the Power of the Arc Sine Test against the CMH Test for Stratified Data for Smaller Proportions Professional Wed, Jun 27 11:00AM Hewa Saranadasa
W 23 Building Novel Clinical Research Capacity in Resource-Limited Settings: Lessons Learned at Three Mozambique Sites Professional Wed, Jun 27 11:00AM Kathleen A. Walker
W 24 Preparing to Share CDISC SDTM Data: A Practical Evaluation of Potential Error Sources and Effective Review Processes Professional Wed, Jun 27 11:00AM Steve Kirby
W 25 Current Drug Master File (DMF) Status in Taiwan Professional Wed, Jun 27 11:00AM Fu-Chieh Lu
W 26 Producing Rules for Portugal to Improve Rational Prescribing Professional Wed, Jun 27 11:00AM Pedro Caetano
W 27 To Develop a Process to Help Patients Adhere to a Prescribed Haemophilia Therapy Regime Professional Wed, Jun 27 11:00AM Chris Watson
© 2015 DIA